The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Monovalent Antivenom Market Research Report 2025
Synopsis
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
The global Monovalent Antivenom market was valued at US$ 384 million in 2023 and is anticipated to reach US$ 477.6 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Monovalent Antivenom, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monovalent Antivenom.
Report Scope
The Monovalent Antivenom market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monovalent Antivenom market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monovalent Antivenom manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Serum Biotech
Segment by Type
Coral Snakes Antivenom
Sea Snakes Antivenom
Brown Snake Antivenom
Others
Segment by Application
Non-profit Institutions
Hospitals and Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monovalent Antivenom manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monovalent Antivenom in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
The global Monovalent Antivenom market was valued at US$ 384 million in 2023 and is anticipated to reach US$ 477.6 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Monovalent Antivenom, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monovalent Antivenom.
Report Scope
The Monovalent Antivenom market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monovalent Antivenom market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monovalent Antivenom manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Serum Biotech
Segment by Type
Coral Snakes Antivenom
Sea Snakes Antivenom
Brown Snake Antivenom
Others
Segment by Application
Non-profit Institutions
Hospitals and Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monovalent Antivenom manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monovalent Antivenom in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Monovalent Antivenom Market Overview
1.1 Product Overview and Scope of Monovalent Antivenom
1.2 Monovalent Antivenom Segment by Type
1.2.1 Global Monovalent Antivenom Market Value Comparison by Type (2024-2030)
1.2.2 Coral Snakes Antivenom
1.2.3 Sea Snakes Antivenom
1.2.4 Brown Snake Antivenom
1.2.5 Others
1.3 Monovalent Antivenom Segment by Application
1.3.1 Global Monovalent Antivenom Market Value by Application: (2024-2030)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Global Monovalent Antivenom Market Size Estimates and Forecasts
1.4.1 Global Monovalent Antivenom Revenue 2019-2030
1.4.2 Global Monovalent Antivenom Sales 2019-2030
1.4.3 Global Monovalent Antivenom Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Monovalent Antivenom Market Competition by Manufacturers
2.1 Global Monovalent Antivenom Sales Market Share by Manufacturers (2019-2024)
2.2 Global Monovalent Antivenom Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Monovalent Antivenom Average Price by Manufacturers (2019-2024)
2.4 Global Monovalent Antivenom Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Monovalent Antivenom, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Monovalent Antivenom, Product Type & Application
2.7 Monovalent Antivenom Market Competitive Situation and Trends
2.7.1 Monovalent Antivenom Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Monovalent Antivenom Players Market Share by Revenue
2.7.3 Global Monovalent Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Monovalent Antivenom Retrospective Market Scenario by Region
3.1 Global Monovalent Antivenom Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Monovalent Antivenom Global Monovalent Antivenom Sales by Region: 2019-2030
3.2.1 Global Monovalent Antivenom Sales by Region: 2019-2024
3.2.2 Global Monovalent Antivenom Sales by Region: 2025-2030
3.3 Global Monovalent Antivenom Global Monovalent Antivenom Revenue by Region: 2019-2030
3.3.1 Global Monovalent Antivenom Revenue by Region: 2019-2024
3.3.2 Global Monovalent Antivenom Revenue by Region: 2025-2030
3.4 North America Monovalent Antivenom Market Facts & Figures by Country
3.4.1 North America Monovalent Antivenom Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Monovalent Antivenom Sales by Country (2019-2030)
3.4.3 North America Monovalent Antivenom Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Monovalent Antivenom Market Facts & Figures by Country
3.5.1 Europe Monovalent Antivenom Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Monovalent Antivenom Sales by Country (2019-2030)
3.5.3 Europe Monovalent Antivenom Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monovalent Antivenom Market Facts & Figures by Country
3.6.1 Asia Pacific Monovalent Antivenom Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Monovalent Antivenom Sales by Country (2019-2030)
3.6.3 Asia Pacific Monovalent Antivenom Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Monovalent Antivenom Market Facts & Figures by Country
3.7.1 Latin America Monovalent Antivenom Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Monovalent Antivenom Sales by Country (2019-2030)
3.7.3 Latin America Monovalent Antivenom Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Monovalent Antivenom Market Facts & Figures by Country
3.8.1 Middle East and Africa Monovalent Antivenom Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Monovalent Antivenom Sales by Country (2019-2030)
3.8.3 Middle East and Africa Monovalent Antivenom Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Monovalent Antivenom Sales by Type (2019-2030)
4.1.1 Global Monovalent Antivenom Sales by Type (2019-2024)
4.1.2 Global Monovalent Antivenom Sales by Type (2025-2030)
4.1.3 Global Monovalent Antivenom Sales Market Share by Type (2019-2030)
4.2 Global Monovalent Antivenom Revenue by Type (2019-2030)
4.2.1 Global Monovalent Antivenom Revenue by Type (2019-2024)
4.2.2 Global Monovalent Antivenom Revenue by Type (2025-2030)
4.2.3 Global Monovalent Antivenom Revenue Market Share by Type (2019-2030)
4.3 Global Monovalent Antivenom Price by Type (2019-2030)
5 Segment by Application
5.1 Global Monovalent Antivenom Sales by Application (2019-2030)
5.1.1 Global Monovalent Antivenom Sales by Application (2019-2024)
5.1.2 Global Monovalent Antivenom Sales by Application (2025-2030)
5.1.3 Global Monovalent Antivenom Sales Market Share by Application (2019-2030)
5.2 Global Monovalent Antivenom Revenue by Application (2019-2030)
5.2.1 Global Monovalent Antivenom Revenue by Application (2019-2024)
5.2.2 Global Monovalent Antivenom Revenue by Application (2025-2030)
5.2.3 Global Monovalent Antivenom Revenue Market Share by Application (2019-2030)
5.3 Global Monovalent Antivenom Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Monovalent Antivenom Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Monovalent Antivenom Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 BTG
6.3.1 BTG Corporation Information
6.3.2 BTG Description and Business Overview
6.3.3 BTG Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BTG Monovalent Antivenom Product Portfolio
6.3.5 BTG Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Monovalent Antivenom Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
6.5.3 Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Haffkine Bio-Pharmaceutical Monovalent Antivenom Product Portfolio
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
6.6 Vins Bioproducts
6.6.1 Vins Bioproducts Corporation Information
6.6.2 Vins Bioproducts Description and Business Overview
6.6.3 Vins Bioproducts Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vins Bioproducts Monovalent Antivenom Product Portfolio
6.6.5 Vins Bioproducts Recent Developments/Updates
6.7 Serum Biotech
6.6.1 Serum Biotech Corporation Information
6.6.2 Serum Biotech Description and Business Overview
6.6.3 Serum Biotech Monovalent Antivenom Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Biotech Monovalent Antivenom Product Portfolio
6.7.5 Serum Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monovalent Antivenom Industry Chain Analysis
7.2 Monovalent Antivenom Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monovalent Antivenom Production Mode & Process
7.4 Monovalent Antivenom Sales and Marketing
7.4.1 Monovalent Antivenom Sales Channels
7.4.2 Monovalent Antivenom Distributors
7.5 Monovalent Antivenom Customers
8 Monovalent Antivenom Market Dynamics
8.1 Monovalent Antivenom Industry Trends
8.2 Monovalent Antivenom Market Drivers
8.3 Monovalent Antivenom Market Challenges
8.4 Monovalent Antivenom Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Monovalent Antivenom Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Monovalent Antivenom Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Monovalent Antivenom Market Competitive Situation by Manufacturers in 2023
Table 4. Global Monovalent Antivenom Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Monovalent Antivenom Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Monovalent Antivenom Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Monovalent Antivenom Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Monovalent Antivenom Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Monovalent Antivenom, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Monovalent Antivenom, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Monovalent Antivenom, Product Type & Application
Table 12. Global Key Manufacturers of Monovalent Antivenom, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monovalent Antivenom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monovalent Antivenom as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Monovalent Antivenom Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Monovalent Antivenom Sales by Region (2019-2024) & (K Units)
Table 18. Global Monovalent Antivenom Sales Market Share by Region (2019-2024)
Table 19. Global Monovalent Antivenom Sales by Region (2025-2030) & (K Units)
Table 20. Global Monovalent Antivenom Sales Market Share by Region (2025-2030)
Table 21. Global Monovalent Antivenom Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Monovalent Antivenom Revenue Market Share by Region (2019-2024)
Table 23. Global Monovalent Antivenom Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Monovalent Antivenom Revenue Market Share by Region (2025-2030)
Table 25. North America Monovalent Antivenom Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Monovalent Antivenom Sales by Country (2019-2024) & (K Units)
Table 27. North America Monovalent Antivenom Sales by Country (2025-2030) & (K Units)
Table 28. North America Monovalent Antivenom Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Monovalent Antivenom Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Monovalent Antivenom Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Monovalent Antivenom Sales by Country (2019-2024) & (K Units)
Table 32. Europe Monovalent Antivenom Sales by Country (2025-2030) & (K Units)
Table 33. Europe Monovalent Antivenom Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Monovalent Antivenom Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Monovalent Antivenom Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Monovalent Antivenom Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Monovalent Antivenom Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Monovalent Antivenom Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Monovalent Antivenom Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Monovalent Antivenom Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Monovalent Antivenom Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Monovalent Antivenom Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Monovalent Antivenom Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Monovalent Antivenom Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Monovalent Antivenom Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Monovalent Antivenom Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Monovalent Antivenom Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Monovalent Antivenom Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Monovalent Antivenom Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Monovalent Antivenom Sales (K Units) by Type (2019-2024)
Table 51. Global Monovalent Antivenom Sales (K Units) by Type (2025-2030)
Table 52. Global Monovalent Antivenom Sales Market Share by Type (2019-2024)
Table 53. Global Monovalent Antivenom Sales Market Share by Type (2025-2030)
Table 54. Global Monovalent Antivenom Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Monovalent Antivenom Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Monovalent Antivenom Revenue Market Share by Type (2019-2024)
Table 57. Global Monovalent Antivenom Revenue Market Share by Type (2025-2030)
Table 58. Global Monovalent Antivenom Price (US$/Unit) by Type (2019-2024)
Table 59. Global Monovalent Antivenom Price (US$/Unit) by Type (2025-2030)
Table 60. Global Monovalent Antivenom Sales (K Units) by Application (2019-2024)
Table 61. Global Monovalent Antivenom Sales (K Units) by Application (2025-2030)
Table 62. Global Monovalent Antivenom Sales Market Share by Application (2019-2024)
Table 63. Global Monovalent Antivenom Sales Market Share by Application (2025-2030)
Table 64. Global Monovalent Antivenom Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Monovalent Antivenom Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Monovalent Antivenom Revenue Market Share by Application (2019-2024)
Table 67. Global Monovalent Antivenom Revenue Market Share by Application (2025-2030)
Table 68. Global Monovalent Antivenom Price (US$/Unit) by Application (2019-2024)
Table 69. Global Monovalent Antivenom Price (US$/Unit) by Application (2025-2030)
Table 70. CSL Corporation Information
Table 71. CSL Description and Business Overview
Table 72. CSL Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. CSL Monovalent Antivenom Product
Table 74. CSL Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck Monovalent Antivenom Product
Table 79. Merck Recent Developments/Updates
Table 80. BTG Corporation Information
Table 81. BTG Description and Business Overview
Table 82. BTG Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. BTG Monovalent Antivenom Product
Table 84. BTG Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Monovalent Antivenom Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Haffkine Bio-Pharmaceutical Corporation Information
Table 91. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 92. Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Haffkine Bio-Pharmaceutical Monovalent Antivenom Product
Table 94. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 95. Vins Bioproducts Corporation Information
Table 96. Vins Bioproducts Description and Business Overview
Table 97. Vins Bioproducts Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Vins Bioproducts Monovalent Antivenom Product
Table 99. Vins Bioproducts Recent Developments/Updates
Table 100. Serum Biotech Corporation Information
Table 101. Serum Biotech Description and Business Overview
Table 102. Serum Biotech Monovalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Serum Biotech Monovalent Antivenom Product
Table 104. Serum Biotech Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Monovalent Antivenom Distributors List
Table 108. Monovalent Antivenom Customers List
Table 109. Monovalent Antivenom Market Trends
Table 110. Monovalent Antivenom Market Drivers
Table 111. Monovalent Antivenom Market Challenges
Table 112. Monovalent Antivenom Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Monovalent Antivenom
Figure 2. Global Monovalent Antivenom Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Monovalent Antivenom Market Share by Type in 2023 & 2030
Figure 4. Coral Snakes Antivenom Product Picture
Figure 5. Sea Snakes Antivenom Product Picture
Figure 6. Brown Snake Antivenom Product Picture
Figure 7. Others Product Picture
Figure 8. Global Monovalent Antivenom Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Monovalent Antivenom Market Share by Application in 2023 & 2030
Figure 10. Non-profit Institutions
Figure 11. Hospitals and Clinic
Figure 12. Global Monovalent Antivenom Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Monovalent Antivenom Market Size (2019-2030) & (US$ Million)
Figure 14. Global Monovalent Antivenom Sales (2019-2030) & (K Units)
Figure 15. Global Monovalent Antivenom Average Price (US$/Unit) & (2019-2030)
Figure 16. Monovalent Antivenom Report Years Considered
Figure 17. Monovalent Antivenom Sales Share by Manufacturers in 2023
Figure 18. Global Monovalent Antivenom Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Monovalent Antivenom Players: Market Share by Revenue in 2023
Figure 20. Monovalent Antivenom Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Monovalent Antivenom Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Monovalent Antivenom Sales Market Share by Country (2019-2030)
Figure 23. North America Monovalent Antivenom Revenue Market Share by Country (2019-2030)
Figure 24. United States Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Monovalent Antivenom Sales Market Share by Country (2019-2030)
Figure 27. Europe Monovalent Antivenom Revenue Market Share by Country (2019-2030)
Figure 28. Germany Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Monovalent Antivenom Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Monovalent Antivenom Revenue Market Share by Region (2019-2030)
Figure 35. China Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Monovalent Antivenom Sales Market Share by Country (2019-2030)
Figure 45. Latin America Monovalent Antivenom Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Monovalent Antivenom Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Monovalent Antivenom Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Monovalent Antivenom Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Monovalent Antivenom by Type (2019-2030)
Figure 55. Global Revenue Market Share of Monovalent Antivenom by Type (2019-2030)
Figure 56. Global Monovalent Antivenom Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Monovalent Antivenom by Application (2019-2030)
Figure 58. Global Revenue Market Share of Monovalent Antivenom by Application (2019-2030)
Figure 59. Global Monovalent Antivenom Price (US$/Unit) by Application (2019-2030)
Figure 60. Monovalent Antivenom Value Chain
Figure 61. Monovalent Antivenom Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
